These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7116507)

  • 21. A new immunoenzymometric assay for bioactive N-terminal human parathyroid hormone fragments and its application in pharmacokinetic studies in dogs.
    Mägerlein M; Hock D; Adermann K; Müller-Beckmann B; Neidlein R; Forssmann WG; Stein K
    Arzneimittelforschung; 1998 Feb; 48(2):199-204. PubMed ID: 9541733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analogues of parathyroid hormone containing D-amino acids: evaluation of biological activity and stability.
    Coltrera M; Rosenblatt M; Potts JT
    Biochemistry; 1980 Sep; 19(18):4380-5. PubMed ID: 7417413
    [No Abstract]   [Full Text] [Related]  

  • 23. Side chain cyclization based on serine residues: synthesis, structure, and activity of a novel cyclic analogue of the parathyroid hormone fragment 1-11.
    Caporale A; Sturlese M; Gesiot L; Zanta F; Wittelsberger A; Cabrele C
    J Med Chem; 2010 Nov; 53(22):8072-9. PubMed ID: 21028829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Site-specific biotinylation. A novel approach and its application to endothelin-1 analogs and PTH-analog.
    Natarajan S; Festin SM; Hedberg A; Liu EC; Floyd DM; Hunt JT
    Int J Pept Protein Res; 1992 Dec; 40(6):567-74. PubMed ID: 1286942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cooperative interaction of arginine-19 and the N-terminal signaling domain in the affinity and potency of parathyroid hormone.
    Tsomaia N; Shimizu M; Shimizu N; Gardella TJ; Mierke DF
    Biochemistry; 2004 Mar; 43(12):3459-70. PubMed ID: 15035617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Synthesis and biological activity of the 1-34 sequence of humen parathormone].
    Milhaud G; Rivaille P; Staub JF; Jullienne A
    C R Acad Hebd Seances Acad Sci D; 1974 Sep; 279(12):1015-8. PubMed ID: 4219301
    [No Abstract]   [Full Text] [Related]  

  • 27. Structural requirements for conserved arginine of parathyroid hormone.
    Barbier JR; MacLean S; Whitfield JF; Morley P; Willick GE
    Biochemistry; 2001 Jul; 40(30):8955-61. PubMed ID: 11467957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stabilized NMR structure of human parathyroid hormone(1-34).
    Barden JA; Cuthbertson RM
    Eur J Biochem; 1993 Jul; 215(2):315-21. PubMed ID: 8344299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parathyroid hormone: chemistry and structure-activity relations.
    Rosenblatt M
    Pathobiol Annu; 1981; 11():53-86. PubMed ID: 6276847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of fully active biotinylated analogues of parathyroid hormone and parathyroid hormone-related protein as tools for the characterization of parathyroid hormone receptors.
    Roubini E; Duong LT; Gibbons SW; Leu CT; Caulfield MP; Chorev M; Rosenblatt M
    Biochemistry; 1992 Apr; 31(16):4026-33. PubMed ID: 1314656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sensitivity of the antibovine parathyroid hormone serum 211/32 to synthetic fragments of human parathyroid hormone.
    Mallette LE
    J Clin Endocrinol Metab; 1980 Jan; 50(1):201-3. PubMed ID: 7350182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the pharmacokinetics of parenteral parathyroid hormone-(1-34) [PTH-(1-34)] and PTH-related peptide-(1-34) in healthy young humans.
    Fraher LJ; Klein K; Marier R; Freeman D; Hendy GN; Goltzman D; Hodsman AB
    J Clin Endocrinol Metab; 1995 Jan; 80(1):60-4. PubMed ID: 7829640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of the guanidine group in the N-terminal fragment of PTH(1-11).
    Caporale A; Woznica I; Schievano E; Mammi S; Peggion E
    Amino Acids; 2010 Apr; 38(4):1269-75. PubMed ID: 19690796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-function relationship studies of bovine parathyroid hormone [bPTH(1-34)] analogues containing alpha-amino-iso-butyric acid (Aib) residues.
    Peggion E; Mammi S; Schievano E; Schiebler L; Corich M; Rosenblatt M; Chorev M
    Biopolymers; 2003 Mar; 68(3):437-57. PubMed ID: 12601801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conformation of parathyroid hormone antagonists by CD, NMR, and molecular dynamics simulations.
    Chorev M; Behar V; Yang Q; Rosenblatt M; Mammi S; Maretto S; Pellegrini M; Peggion E
    Biopolymers; 1995 Oct; 36(4):485-95. PubMed ID: 7578943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Total solid-phase synthesis, purification, and characterization of human parathyroid hormone-(1-84).
    Fairwell T; Hospattankar AV; Ronan R; Brewer HB; Chang JK; Shimizu M; Zitzner L; Arnaud CD
    Biochemistry; 1983 May; 22(11):2691-7. PubMed ID: 6871156
    [No Abstract]   [Full Text] [Related]  

  • 37. Renal effects of native parathyroid hormone and synthetic biologically active fragments in pseudohypoparathyroidism and hypoparathyroidism.
    Neer RM; Tregear GW; Potts JT
    J Clin Endocrinol Metab; 1977 Feb; 44(2):420-3. PubMed ID: 190258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strategy for the synthesis of large peptides: an application to the total synthesis of human parathyroid hormone [hPTH (1-84)].
    Kimura T; Takai M; Masui Y; Morikawa T; Sakakibara S
    Biopolymers; 1981 Sep; 20(9):1823-32. PubMed ID: 7306668
    [No Abstract]   [Full Text] [Related]  

  • 39. Synthesis and structural identification of fluorine-18 labeled parathyroid hormone.
    Yang Y; Richter S; Wuest F; Doschak MR
    J Labelled Comp Radiopharm; 2015; 58(11-12):453-7. PubMed ID: 26356136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parathyroid-hormone fragment.
    Milhaud G; Rivaille P; Staub JF
    Lancet; 1973 Aug; 2(7826):440. PubMed ID: 4124911
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.